Coronavirus disease 2019 (COVID-19) is a respiratory disease caused by a novel virus called severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) ([@bib0055]). The outbreak of this disease was first reported in December 2019 in Wuhan, China ([@bib0080]). The virus can spread from human to human through droplets or contaminated surfaces ([@bib0070]). It has an incubation period of 2--14 days and viral shedding has been reported in pre-symptomatic and asymptomatic carriers ([@bib0065], [@bib0070]). Compared to the coronavirus causing severe acute respiratory syndrome (SARS), the transmissibility of this virus is higher, with an estimated basic reproductive number of 2.24--3.58 depending on the setting ([@bib0070]). COVID-19 was declared a public health emergency of international concern (PHEIC) on January 30, 2020 ([@bib0155]).

The disease has now spread to most countries in Africa ([@bib0100], [@bib0160]). This is partly because of air travel interconnectivity and volume and the transmission efficacy of the virus itself ([@bib0050], [@bib0070]). Since the introduction of the first case in February 2020, the number of cases on the continent has grown to more than 100 000 ([@bib0160]). A modelling study conducted by the World Health Organization (WHO) predicted that with widespread community transmission, an estimated 223 281 401 (representing 22% of the continent's population) will become infected within the next 1 year ([@bib0015]). The highest number of cases are expected in Nigeria, Algeria, and South Africa ([@bib0015]). Out of the total cases, an estimated 36 967 532 will develop symptoms and 150 078 will die ([@bib0015]). Based on this scenario, 4 637 240 Africans will require hospital admission, out of which 139 521 will require oxygen therapy and 89 043 will require ventilatory support ([@bib0015]). A surge in COVID-19 cases will place enormous strain on the continent's health systems, diminishing healthcare resources as already seen in other places ([@bib0045]), as well as funds and health worker time among others. The magnitude of this shock could cause the performance of health programmes to drastically decline.

To mitigate widespread transmission, African governments, like their counterparts in other parts of the world, have rolled out several COVID-19 control strategies ([@bib0100]). Based on lessons learnt from countries that are at advanced stages of the epidemic ([@bib0075], [@bib0115]), physical distancing is one of the key interventions that is being prioritized across the continent, in addition to strategies such as hand hygiene and the use of facemasks among others. The goal of physical distancing is to limit interaction between people, as the disease can be transmitted from person to person ([@bib0025]). To enforce physical distancing, lockdowns are being imposed at the national or sub-national level ([@bib0060]). In some countries, these lockdown orders have been accompanied by roadblocks to restrict the movement of people and vehicles. These can have unintended negative consequences on access to routine essential health services.

One of the routine health services that is being disrupted by COVID-19 is childhood immunization. According to the World Health Organization, an estimated 80 million children in 68 countries are at risk of developing vaccine-preventable diseases such as measles, diphtheria, and polio, because of the disruption of routine immunization services ([@bib0150]). This is not surprising, as the immunization system relies on functioning health facilities and stable communities to be effective. In fact, the WHO recommended the suspension of mass vaccination campaigns to prevent the worsening of community transmission of COVID-19 ([@bib0155]) and this could have an immediate effect on immunization coverage, especially in rural and underserved communities.

Africa is of particular concern because the performance of immunization programmes on the continent even in the pre-COVID-19 era was largely sub-optimal ([@bib0140]). In the WHO African region, coverage with the third dose of diphtheria--tetanus--pertussis-containing vaccine (DTP3) has stagnated at 76%, a level it attained in 2016 ([@bib0135]). According to WHO--UNICEF estimates of immunization coverage, the national DTP3 coverage level was less than 90% in 26 out of the 47 countries in the region in 2018 ([@bib0145]). The coverage level for these countries is shown in [Figure 1](#fig0005){ref-type="fig"} . Nigeria and South Africa are among the countries that are expected to have the highest numbers of COVID-19 cases, and the DTP3 coverage level in these countries was recently reported as 57% and 74%, respectively ([@bib0145]). Countries like Equatorial Guinea, Chad, and Guinea have DTP3 coverage as low as 25%, 41%, and 45%, respectively ([@bib0145]). Single-dose measles-containing vaccine (MCV1) coverage for the region is at 74%, and only eight countries have attained the recommended 95% MCV1 coverage level ([@bib0140]). At this rate, most countries are unlikely to meet the Global Vaccine Action Plan (GVAP) targets for DTP3 or measles elimination ([@bib0130]). The impact of the COVID-19 outbreak could cause immunization performance to decline even further.Figure 1DTP3 coverage for countries in the WHO-AFRO region.Figure 1

Historical evidence from previous epidemics like the Ebola outbreak in West Africa, has shown that the indirect effect of such events exacerbates morbidity and mortality ([@bib0040]). This is because overall healthcare utilization declines ([@bib0125]). Suk and colleagues ([@bib0120]) found that multiple epidemics of measles occurred in 2015 in Guinea because of the breakdown in public health systems, particularly immunization, on account of Ebola. If COVID-19 is allowed to trigger a similar breakdown of immunization systems, child mortality on the continent caused by vaccine-preventable diseases could increase significantly. The recently released World Health Statistics 2020 shows that African countries are already lagging behind in their progress towards achieving the child mortality targets for the sustainable development goals ([@bib0165]).

In a recent study, scientists showed that the benefit of sustaining routine immunization in Africa is greater than the risk of COVID-19 deaths that could result from visiting health services for immunization ([@bib0030]). This evidence underscores the value of immunization during COVID-19 and provides justifications for rapid action from governments and their partners. Hence, policymakers must quickly identify robust and context-specific strategies to rapidly scale up routine immunization in order to mitigate the impact of COVID-19 on their national immunization performance.

Typically, in public health, efforts to explore population-based problems often focus on specific areas without giving due recognition to the patterns that exist within systems ([@bib0020]). Nonetheless, the real world continues to function as complex adaptive systems (CAS) ([@bib0105]). For this reason, we propose an alternative viewpoint that departs from this reductionist philosophy to systems science in exploring the interaction between COVID-19 and immunization ([@bib0085]). This will inform a more nuanced and holistic understanding of how they interrelate. So, instead of studying individual components of the immunization system (e.g., vaccine supply and logistics), a systems-based approach that conceptualizes all components of the system as interrelated entities should be adopted. Although complex, this approach will explicitly expose the non-linear and dynamic relationships that exist between all elements of the system ([@bib0085]).

A range of methodologies for understanding complexity exist, one of which is systems dynamic modelling ([@bib0105]). This modelling technique can be used to analyse multiple, simultaneous, and complex interactions over time ([@bib0105]). A commonly used tool in systems dynamic modelling is the causal loop diagram (CLD) ([@bib0105]). It provides qualitative illustrations of the causal linkages between elements of a system, as well as the feedback loops (balancing and reinforcing) that exist between them ([@bib0105]).

As an example, the CLD in [Figure 2](#fig0010){ref-type="fig"} was constructed using Vensim PLE version 8.0.6 to illustrate the relationship between COVID-19, its control strategies, and immunization. The model revealed the linkage between COVID-19 cases and lockdown as a balancing loop. This means that an increase in the number of COVID-19 cases will prompt the government to impose lockdown as a containment strategy. This lockdown decreases transmission events, which will then cause the number of COVID-19 cases to decline. If the number of COVID-19 cases should surge, there will be a decrease in the number of health workers that are available to provide routine immunization services. This is because they would be redeployed to COVID-19-related tasks. Similarly, it will decrease available health facilities, as hospital and clinics will be converted to COVID-19 treatment and isolation centres. In addition, immunization funding will reduce, as funds will be diverted to the COVID-19 response. All of these will contribute to a decrease in the availability of immunization services.Figure 2A causal loop diagram showing the relationship between COVID-19 and the immunization system (B = balancing loop; R = reinforcing loop).Figure 2

Lockdown can directly affect immunization services by constraining access to vaccines. The presence of roadblocks dissuades caregivers from visiting health facilities for routine immunization. Vaccine logistics and the supply chain at the first and last mile are interrupted. Furthermore, public transportation services that facilitate the movement of caregivers and health workers to health facilities are stopped. An indirect effect of the lockdown on immunization is through its vicious cycle relationship with the economy. Its restrictive nature can be detrimental to vulnerable individuals whose source of livelihood depends on informal economic activities. The resultant poverty can further widen socioeconomic inequalities and this has been shown to affect immunization coverage ([@bib0010]).

Community mobilization activities would decrease with a resultant decrease in mass vaccination campaigns. This is because of the balancing loop that exists between vaccination campaigns and transmission risk. Conducting vaccination campaigns during the COVID-19 pandemic increases the contact rate in communities, which accentuates the transmission risk.

This simple CLD demonstrated that many elements are interacting with the immunization systems and that a change in one part of the system causes a cascade of changes in other parts. The advantage of presenting the structure of a system in this manner is that it explicitly depicts dynamic relationships. Using this to guide planning and the prioritization of areas for intervention will pave the way for system re-design and improvement.

Implementation science concepts can support immunization system re-design to adjust it to the pressures of COVID-19 by accelerating the uptake and utilization of multifaceted evidence-based strategies in policies and practice settings to improve system performance ([@bib0035]). For example, the risk of health worker infection is a challenge in the practice setting that could be minimized by using personal protective equipment (PPE). Tailored implementation strategies could be used to improve the adoption, implementation, and scale-up of this PPE in immunization clinics and other facility service delivery points ([@bib0110]). In some settings, rapid improvements in PPE use can even be engineered using quality improvement ([@bib0090]).

Implementation science can be used to improve strategy 'fit' by ensuring critical consideration of context in COVID-19-related policies ([@bib0095]). This will change how policymakers and public health experts approach the outbreak vis-à-vis the health system. It could encourage the use of differentiated models for communities, population groups, and socioeconomic strata, among others. For example, existing structures like patent medicine vendors can be engaged to provide immunization services in slums and hard-to-reach areas when health facilities are overwhelmed ([@bib0005]). A common constraint is the inability of health workers in some settings to reach health facilities because of disruption to the public transport system caused by lockdown. This is likely to be more prominent in underserved communities where alternative options might be limited. To address this, a special transportation scheme could be introduced to improve the mobility of health workers. To ease caregiver movement through roadblocks and promote adherence to the immunization schedule, the child home-based record could be regarded as a 'pass'.

Implementation science also emphasizes the need to tailor information needs to the demand of different stakeholders. Community members are prone to misinformation about COVID-19. When coupled with policies like lockdown, they could potentially increase vaccine hesitancy among caregivers. To address this, appropriately tailored information about the novel disease, including recommended preventive strategies like use of a facemask when in public, could be communicated with community members. In addition, the importance of infant immunization could be re-emphasized to motivate caregivers to continue scheduled immunization visits.

In conclusion, integrating systems thinking and implementation science in health planning and decision-making could help African countries gain a better understanding of the influence of COVID-19 on health programmes, such as childhood immunization, and facilitate the implementation of multifaceted evidence-based strategies in complex practice settings. As Africa re-strategizes for the post-2020 era, these emerging fields could contribute significantly in accelerating progress towards universal access to vaccines for all children on the continent despite COVID-19.
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